|会社名||T Rowe Price Group Inc. （Tロウ・プライス・グル―プ）|
|概要||事業概要 ティー・ロウ・プライス・グループ（T. Rowe Price Group Inc.）は金融サービス持株会社である。同社は子会社を通じて世界の投資家にグローバルな投資管理サービスを提供する。同社は個人、アドバイザー、機関、金融仲介業者および退職プランスポンサーに、米国ミューチュアルファンド、その他スポンサードプール投資ビークル、サブアドバイザリーサービス、個別口座管理、記録保管および関連サービスのスポンサーを提供している。同社は北米、欧州中東及びアフリカ（EMEA）、アジア太平洋（APAC）の3地域に拠点を置く国で製品を販売する。また、安定的なバリュー投資契約の管理、サードパーティのベンチャーキャピタル投資プールから顧客が受け取る持分証券の処分に関する流通管理サービスなど、専門的なアドバイザリーサービスも提供する。 Tロウ・プライス・グル―プは米国の金融サ―ビス持株会社。米国内の個人投資家や確定拠出型年金制度(401Kプラン)、また、米国内外の機関投資家にTロウ・プライス投資信託を中心に米国内外株式、債券、マネ―マ―ケットファンド、その他投資商品への投資アドバイス、投資信託代行業務、401K口座管理、金融商品仲介、預金口座、信託業務などのサ―ビスを提供。 Founded in 1937, Baltimore-based T. Rowe Price Group, Inc. is a global investment management organization with $1.46 trillion in assets under management as of January 31, 2021. The organization provides a broad array of mutual funds, subadvisory services, and separate account management for individual and institutional investors, retirement plans, and financial intermediaries. The company also offers sophisticated investment planning and guidance tools. T. Rowe Price’s disciplined, risk-aware investment approach focuses on diversification, style consistency, and fundamental research.|
|本社所在地||100 East Pratt Street Baltimore MD 21202 USA|
|代表者氏名||William J. Stromberg ウィリアムJ.ストロンバーグ|
|代表者役職名||President Chief Executive Officer Director 社長兼最高経営責任者（CEO）|
|市場名||NASDAQ National Market System|
|決算概要||決算概要 BRIEF: For the six months ended 30 June 2018 T. Rowe Price Group Inc revenues increased 15% to $2.67B. Net income applicable to common stockholders increased 19% to $881.5M. Revenues reflect Fees for Other Customer Services increase of 18% to $2.4B. Net income benefited from Advertising and promotion decrease of 2% to $43.6M (expense). Dividend per share increased from $1.11 to $1.27.|
T. Rowe Price Group, Inc. (NASDAQ:TROW) Shares Bought by Private Advisor Group LLC 2021/12/02 11:12:43 Transcript Daily
Private Advisor Group LLC grew its stake in shares of T. Rowe Price Group, Inc. (NASDAQ:TROW) by 65.2% in the third quarter, HoldingsChannel reports. The fund owned 24,018 shares of the asset managers stock after buying an additional 9,476 shares during the quarter. Private Advisor Group LLCs holdings in T. Rowe Price Group were worth 
Off-Exchange Trading Evolves 2021/12/01 07:00:00 Traders Magazine
With Mehmet Kinak, Global Head of Systematic Trading and Market Structure, T. Rowe Price
Great Valley Advisor Group Inc. Sells 108 Shares of T. Rowe Price Group, Inc. (NASDAQ:TROW) 2021/11/30 12:22:43 Dakota Financial News
Great Valley Advisor Group Inc. trimmed its holdings in shares of T. Rowe Price Group, Inc. (NASDAQ:TROW) by 4.9% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,090 shares of the asset managers stock after selling 108 shares during the period. Great Valley Advisor Group 
T. Rowe Price Group, Inc. (NASDAQ:TROW) Shares Bought by DNB Asset Management AS 2021/11/29 11:54:44 Transcript Daily
DNB Asset Management AS lifted its position in shares of T. Rowe Price Group, Inc. (NASDAQ:TROW) by 31.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 55,043 shares of the asset managers stock after buying an additional 13,109 shares 
Latitude Advisors LLC Invests $361,000 in T. Rowe Price Group, Inc. (NASDAQ:TROW) 2021/11/28 11:44:41 Dakota Financial News
Latitude Advisors LLC bought a new position in T. Rowe Price Group, Inc. (NASDAQ:TROW) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,833 shares of the asset managers stock, valued at approximately $361,000. Several other hedge funds also recently 
What Investors Should Know About Ginkgo Bioworks SPAC Deal: 'Cell Programming Has The Potential To Impact Every Physical Goods Industry' 2021/05/11 19:29:59 Benzinga
A well seasoned SPAC management team announced a SPAC deal Tuesday to bring a cell programming company public. The SPAC Deal: Ginkgo Bioworks is going public in a SPAC deal with Soaring Eagle Acquisition Corp (NASDAQ: SRNG ) that values the company at a pre money equity value of $15 billion. Soaring Eagle Acquisition Corp is a SPAC from Harry Sloan and Jeff Sagansky, a seasoned SPAC team that previously brought DraftKings Inc (NASDAQ: DKNG ) and Skillz (NYSE: SKLZ ) public. The SPAC merger includes an oversubscribed PIPE of $775 million from key investors that included Baillie Gifford, Bain Capital, T. Rowe Price, Ark Investment Management and Cascade Investment, led by Bill Gates. Current Soaring Eagle Acquisition shareholders will own 10% of the company post merger. About Ginkgo Bioworks: Building a leading horizontal platform for … Full story available on Benzinga.com
Fidelity cuts Ant Group's valuation in half to $144 billion after regulatory crackdown in China 2021/05/03 13:38:53 Business Insider
Summary List Placement Fidelity cut Ant Group's implied valuation to $144 billion from $300 billion, according to regulatory filings. The decline in valuation comes after China imposed a regulatory crackdown on the fintech giant. Fidelity initially invested in Ant Group in June 2018 at a $150 billion valuation. Sign up here for our daily newsletter, 10 Things Before the Opening Bell . China's regulatory crackdown of Ant Group in recent months has led Fidelity to cut its implied valuation of the fintech giant in half, according to regulatory filings first seen by The Wall Street Journal. Fidelity's implied valuation of Ant Group fell to $144 billion from $295 billion, according to the filing. Fidelity first invested in Ant Group in June 2018 at a valuation of $150 billion. The implied valuation represents a massive drop from last year's expected IPO valuation of more than $310 billion. Fidelity isn't the only US money manager that invested in Ant Group prior to its IPO. BlackRock and T.
3 takeaways from a top Democratic senator's new book on monopolies that should have Big Pharma worried 2021/04/27 19:28:22 Business Insider
Summary List Placement Federal officials are increasing scrutiny of mergers and acquisitions in the biotech and pharma industry, and it's spooking analysts and investors. In recent months, the Federal Trade Commission has announced the creation of an international working group to review how pharmaceutical mergers, in particular, are handled. Some of the deals going through the FTC, such as Illumina's $7.1 billion purchase of Grail , have been contested as attempts to dominate a market . This increased scrutiny and other "regulatory activism" led one of Wall Street's top analysts, SVB Leerink's Geoffrey Porges, to downgrade biopharma stocks last month. Now, one of Congress' leading monopoly-busters and a recent front-runner for attorney general , Sen. Amy Klobuchar, has published a book detailing how she would combat what she sees as monopolies and other anticompetitive measures building up in the US. And the pharmaceutical industry is right in her line of sight. Klobuchar, a Minnesota Democrat, doesn't just take aim at companies acquiring one another.
The surge of retail traders entering the stock market is straining systems for online brokers (INX, DJIA, COMPX, NDX, RUT) 2021/04/27 17:01:55 Business Insider
Summary List Placement Retail investors using online brokerage accounts are increasingly running into problems, including issues with trade executions as companies deal with a jump in the number of clients, according to a study published Tuesday. Retail brokers have struggled to ensure a smooth customer experience as the industry opened more than 10 million new accounts in 2020, underscoring the surge in interest in investing during the COVID-19 pandemic, said data analytics firm J.P. Power. Troubles with websites, trade processing and execution, and account statements are among the most frequent sources of problems for retail investors, said J.D. Power whose survey was based on the responses of 4,895 investors who said they make all their investment decisions without consulting a full-service, dedicated financial advisor. The firm said problem incidence has doubled in the past year, affecting 11% of all Do-It-Yourself investors and 12% of those in the seeking-guidance segment of self-directed investors. "The significant influx of new investors — and increased trading volumes and overall engagement from clients — clearly put a strain on the system and a spotlight on some of the most critical areas that firms need to address if they want to continue to attract and retain self-service investors," Michael Foy, head of wealth intelligence at J.D.
8 e-commerce retail brands expected to boom in 2021, according to industry experts 2021/04/23 14:21:27 Business Insider
Summary List Placement 2021 looks to be a good year for e-commerce after 2020 saw the sector blow past investor expectations. According to e-commerce platform Shopify , retail e-commerce enjoyed 10 years' worth of growth in as little as 90 days due to the COVID-19 pandemic. With consumers more reliant than ever on online shopping, the coronavirus pandemic sparked soaring online sales . Plenty of major e-commerce companies may even go public in the coming months . But which e-commerce outfits are truly on the verge of booming in 2021? Business Insider analyzed the numbers from private capital data firm PitchBook Data and spoke to experts in the industry to find out which companies could see the most opportunity come their way in the coming months. SEE ALSO: Online retailer Wish just landed a $17 billion valuation in its IPO. Here are 21 other ecommerce companies experts say could go public in 2021. Instacart Investors : D1 Capital Partners, T. Rowe Price, PV Seed Fund, General Catalyst, Regah Ventures, DST Global, The Spaventa Group, and Valiant Capital Partners Latest funding : Series G and Series H Funding size : $550 million in 2020 Headquarters : San Francisco What it does : Instacart is a food and essential goods delivery company.
Ark Funds, Illumina Invest In SomaLogic SPAC Deal: What Investors Should Know 2021/03/29 15:16:06 Benzinga
A leader in the proteomics field is going public with a SPAC deal announced Monday. The SPAC Deal: SomaLogic announced a SPAC deal with CM Life Sciences II Inc (NASDAQ: CMIIU ), valuing the company at $1.2 billion. A $375 million PIPE on the SPAC merger includes investments from SoftBank Group Corp (OTC: SFTBY ), T. Rowe Price, Illumina, Inc. (NASDAQ: ILMN ), Novartis AG (NYSE: NVS ) and accounts advised by Ark Invest. Kevin Conroy, the CEO of EXACT Sciences Corporation (NASDAQ: EXAS ) will join the board of directors after the merger is complete. Current shareholders of CM Life Sciences II will own 14% of the company after the merger. PIPE investors will own 20% of the company after the merger. About SomaLogic: Using … Full story available on Benzinga.com
Rivian to install more than 10,000 EV chargers by end of 2023 2021/03/18 19:41:45 TechCrunch
Rivian, the EV startup backed by Amazon, Cox Automotive and T. Rowe Price, plans to building out a network of more than 10,000 chargers by the end of 2023 in a network aimed at quickly powering its electric vehicle models on highways and at further afield locations next to hiking and mountain biking trailheads and […]
T. Rowe Price Is Pruning Its Money Funds. Will It Stop There? 2021/03/18 14:47:00 Barron's
T. Rowe Price announced this week that it would be liquidating one money fund and merging two others out of existence. What that means for the troubled asset class.
T. Rowe Price Launches its First Impact Fund - ESG Today 2021/03/17 19:30:27 ESG Today
T. Rowe Price announced today the launch of its new Global Impact Equity Fund, the first impact fund for the global investment manager. According to T. Rowe Price, the new fund aims to enable investors to simultaneously pursue their financial goals and to have a positive impact on the global environment and social equity issues. […]
T. Rowe Price Group, Inc. (NASDAQ:TROW) Shares Acquired by First Mercantile Trust Co. 2021/03/13 17:44:43 Modern Readers
First Mercantile Trust Co. lifted its position in shares of T. Rowe Price Group, Inc. (NASDAQ:TROW) by 24.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,802 shares of the asset manager’s stock after acquiring an additional 355 shares during […]
関連キーワード （投資管理_ファンドオペレ―タ― 米国株 Tロウ・プライス・グル―プ TROW T. Rowe Price Group Inc.）